Shmuel Ben Zvi
Director/Board Member chez BANK LEUMI LE-ISRAEL B.M.
Fortune : - $ au 31/03/2024
Profil
Shmuel Ben Zvi is an Independent Director at Bank Leumi Le-Israel B.M.
since 2015 and at Protalix Biotherapeutics, Inc. since 2022.
He is also the Manager & Owner of Shmuel (Muli) Ben Zvi Ltd.
Dr. Ben Zvi previously served as the Deputy CEO, VP-Finance & Strategy at Teva Pharmaceutical Industries Ltd.
from 2004 to 2014.
He was an Independent Non-Executive Director at Vascular Biogenics Ltd.
from 2018 to 2023.
Additionally, he held the position of Head-Budget Department at Israel Ministry of Defense from 2000 to 2004.
Dr. Ben Zvi has an educational background from Tel-Aviv University, where he obtained undergraduate, graduate, and doctorate degrees.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/09/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Shmuel Ben Zvi
| Sociétés | Poste | Début |
|---|---|---|
| BANK LEUMI LE-ISRAEL B.M. | Director/Board Member | 29/07/2015 |
| PROTALIX BIOTHERAPEUTICS, INC. | Director/Board Member | 30/06/2022 |
| Shmuel (Muli) Ben Zvi Ltd. | Corporate Officer/Principal | - |
Anciens postes connus de Shmuel Ben Zvi
| Sociétés | Poste | Fin |
|---|---|---|
| NOTABLE LABS, LTD. | Director/Board Member | 16/10/2023 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/12/2014 |
| Israel Ministry of Defense | Corporate Officer/Principal | 01/01/2004 |
| SOL-GEL TECHNOLOGIES LTD. | Director/Board Member | - |
Formation de Shmuel Ben Zvi
| Tel-Aviv University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BANK LEUMI LE-ISRAEL B.M. | Finance |
| SOL-GEL TECHNOLOGIES LTD. | Health Technology |
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Israel Ministry of Defense | Government |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
| Shmuel (Muli) Ben Zvi Ltd. |
